Abstract:This study aimed to obtain tyrosinase inhibitors for treating hyperpigmentation. A series of cinnamyl ester analogues were designed and synthesized with cinnamic acid (CA) and peaonol compounds. The safety, melanin content and inhibitory effects of all target compounds were evaluated. In the enzymatic activity test, the inhibitory rate of compounds 8, 13 and 14 had stronger inhibitory activity with the IC50 values of 20.7 μM, 13.98 μM and 15.16 μM, respectively than the positive drug kojic acid (IC50 with 30.83 μM). The cytotoxicity evaluation showed that compounds 13 and 14 have higher safety than the other compounds to the proliferation of B16F10 cells. The result of the melanocyte test supported that compound13 has stronger cellular tyrosinase inhibitory activity than kojic acid and arbutin at 100 μM and 200 μM. The enzyme kinetics mechanism revealed that compound 13 was a non-competitive inhibitor while compounds 8 and 14 were mixed inhibitors. For the experiments of melanin content and tyrosinase activity in the B16F10 melanona cells, the inhibition rates of compounds 8, 14 and 13 were with 19.62%, 20.59% and 23.83%, respectively. In addition, compound 13 revealed the highest inhibitory activity to tyrosinase in the melanocyte with inhibition rates of 23.83%, which was better than kojic acid and arbutin (19.21% and 20.45%) at the same concentration. In the anti-melanogenesis experiment, compounds 8 and 13 had better anti-melanin effects than kojic acid from 25 μM to 100 μM. In summary, the results indicated that compounds 8, 13 and 14 had better tyrosinase inhibitory activity and anti-melanogenesis activity. Especially, the compound 13 has potentiality to develop novel tyrosinase inhibitors and whitening agents. The docking studies results revealed that the functional group of compound 13 mostly depends on the phenolic hydroxyl moiety, and its hydroxyl group did not insert into the active site of tyrosinase, which was in agreement with the results of the kinetics study.

Design, synthesis and evaluation of cinnamic acid ester derivatives as mushroom tyrosinase inhibitors.

Synthesis and Biological Evaluation of Novel Methyl 2-Hydroxy-5-Substituted Benzoate Derivatives as Mushroom Tyrosinase Inhibitors

Synthesis and biological evaluation of novel 4-hydroxybenzaldehyde derivatives as tyrosinase inhibitors.

Methoxy-Substituted Tyramine Derivatives Synthesis, Computational Studies and Tyrosinase Inhibitory Kinetics

Synthesis of Cinnamic Acid-Coumarin Ester Analogs and Inhibition of Tyrosinase Activity

Inhibitory Kinetics of Chlorocinnamic Acids on Mushroom Tyrosinase

Design and Synthesis of Thiourea Derivatives with Sulfur-Containing Heterocyclic Scaffolds As Potential Tyrosinase Inhibitors

Design, synthesis, and inhibitory activity of hydroquinone ester derivatives against mushroom tyrosinase

Synthesis, Anti-Tyrosinase Activity, and Spectroscopic Inhibition Mechanism of Cinnamic Acid–Eugenol Esters

Synthesis and Biological Evaluation of Polyhydroxy Benzophenone As Mushroom Tyrosinase Inhibitors

Synthesis, Characterization and Biological Evaluation of Paeonol Thiosemicarbazone Analogues As Mushroom Tyrosinase Inhibitors.

Alpha-substituted Derivatives of Cinnamaldehyde As Tyrosinase Inhibitors: Inhibitory Mechanism and Molecular Analysis.

Kinetic and in silico studies of novel hydroxy-based thymol analogues as inhibitors of mushroom tyrosinase

Tyrosinase Inhibitory Effects and Antioxidative Activities of Novel Cinnamoyl Amides with Amino Acid Ester Moiety.

Discovery of 4-Functionalized Phenyl-O-β-d-glycosides As a New Class of Mushroom Tyrosinase Inhibitors

Design and Synthesis of 3,5-Diaryl-4,5-dihydro-1h-pyrazoles As New Tyrosinase Inhibitors.

Design, synthesis of Cinnamyl-paeonol derivatives with 1, 3-Dioxypropyl as link arm and screening of tyrosinase inhibition activity in vitro

Refinement of Arylthiosemicarbazone Pharmacophore in Inhibition of Mushroom Tyrosinase

Inhibition effects of benzylideneacetone, benzylacetone, and 4-phenyl-2-butanol on the activity of mushroom tyrosinase.

Novel Anti-Melanogenic Compounds, (Z)-5-(Substituted Benzylidene)-4-thioxothiazolidin-2-one Derivatives: In Vitro and In Silico Insights

Inhibitory Effects, Fluorescence Studies, and Molecular Docking Analysis of Some Novel Pyridine-Based Compounds on Mushroom Tyrosinase